UPDATED Apr 21, 2024
Financially healthy companies listed on Asian stock exchanges with an impressive track record.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
FRU | €5.30 | -8.6% | 39.5% | €110.3m | €8.80 | PE10x | E25.5% | 3.7% | Diversified Financials | ||
FRU | €5.10 | -10.5% | 31.4% | €110.3m | €8.47 | PE10x | E25.5% | 3.7% | Diversified Financials | ||
91P | €8.95 | 1.1% | -17.1% | €102.8m | n/a | PE14.1x | E17.0% | 1.5% | Media | ||
8QM | zł3.28 | -1.4% | -4.2% | zł420.6m | zł4.00 | PE23.6x | E57.3% | 2.8% | Tech | ||
96W | kr1.55 | -3.7% | 20.2% | kr1.0b | kr2.00 | PE25.7x | E44.7% | 0.5% | Tech | ||
PBDA | US$1.04 | -4.3% | -50.7% | US$84.0m | US$11.81 | PE10.1x | E96.5% | n/a | Pharmaceuticals & Biotech | ||
RJ1 | kr3.21 | 13.0% | 12.2% | kr818.0m | kr4.02 | PE40.2x | E26.9% | 0% | Software | ||
2U0 | €20.80 | -2.3% | 10.3% | €65.5m | €29.22 | PE21.1x | E36.3% | 4.4% | Capital Goods | ||
1CW | kr2.80 | -1.8% | -21.3% | kr701.6m | kr2.83 | PE15.2x | E21.7% | 6.6% | Software | ||
B9O2 | UK£0.74 | 2.1% | 140.3% | UK£49.2m | UK£1.09 | PE13.5x | E36.2% | n/a | Materials | ||
U6O | kr1.72 | 5.8% | -23.6% | kr584.0m | kr2.15 | PE76x | E54.0% | 2.5% | Software | ||
ZC8 | UK£0.56 | 0% | -11.0% | UK£40.5m | n/a | PE6.7x | E35.4% | 2.8% | Media | ||
Y8E | €1.63 | -8.4% | -10.4% | €36.7m | €2.60 | PE27.6x | E34.5% | n/a | Software | ||
8BD | kr0.79 | 3.7% | -19.6% | kr382.9m | n/a | PE15.3x | E23.7% | 0% | Healthcare | ||
52X | kr2.60 | -8.5% | 2.4% | kr334.8m | kr3.35 | PE27.4x | E35.4% | n/a | Pharmaceuticals & Biotech | ||
8QL | kr0.43 | -0.9% | 40.8% | kr284.7m | n/a | PE31.6x | E30.5% | n/a | Capital Goods | ||
N7W | €2.66 | -5.0% | n/a | €20.7m | €6.35 | PE13.2x | E32.0% | 0.5% | Media | ||
MA10 | €2.30 | 0% | -2.5% | €7.5m | €4.64 | PE36.1x | E46.0% | n/a | Diversified Financials | ||
MA10 | €2.32 | 1.8% | -3.3% | €7.5m | €4.68 | PE36.1x | E46.0% | n/a | Diversified Financials |